黑料吃瓜群网

Virtus, 23Strands and Monash receive funding for IVF study


Monday, 11 December, 2023

Virtus, 23Strands and Monash receive funding for IVF study

Virtus Health, healthtech startup 23Strands and Monash University have received $3m in federal government funding for an IVF study.

The researchers are studying how whole genome sequencing can be used to achieve better patient outcomes with IVF medications. James Pyne, Virtus Health CEO, said, 鈥淭he impact of this grant has huge potential to benefit all IVF patients and is a significant step forward for IVF research and innovation.

鈥淗aving a better understanding of a patient鈥檚 genomic sequencing can help clinicians deliver improved fertility insights, treatments and personalised medicine, and ultimately better success rates,鈥 Pyne said.

Lead researcher Professor Beverley Vollenhoven from Monash University said the study has the potential to revolutionise the entire landscape of fertility care.

鈥淭he groundbreaking collaboration of integrating genomics, artificial intelligence and clinical care aspires to set a new global standard to positively improve women鈥檚 responses to IVF medications,鈥 Vollenhoven said.

By understanding how a woman鈥檚 genes can affect how they respond to IVF medications, the study鈥檚 end goal is to create an AI-driven tool to deliver better targeted doses and improve IVF success rates.

A recent pilot study by Virtus Health and 23Strands found genetic variations mean every woman has a different response to ovarian stimulation medication.

The MRFF grant will enable the research team to build on these preliminary findings and conduct a four-year randomised control trial (RCT) to help develop a tool for personally targeted dosing of medications.

23Strands co-founder and CEO Mark Grosser said the project will be using new ways to process information about IVF treatments. The company combines data from scientific research, medical records and genetics to deliver tailored personalised medical reports for women.

A/Prof Vinayak Smith, Head of New Ventures at Virtus Health, said with this new study the company aims to offer whole-genome sequencing and AI to augment reproductive decision-making and help people achieve their dream of starting a family.

Image credit: iStockphoto.com/luismmolina

Related News

Victoria's Q3 median ED wait times the lowest on record

Victoria's quarter three performance data (January–March) has shown improvement across...

Irregularities in a clinician's cases prompt 15-month lookback

St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...

Two researchers receive $899,000 in cardiovascular funding

In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...



Content from other channels on our network


  • All content Copyright 漏 2025 黑料吃瓜群网-Farrow Pty Ltd